Two new drimane sesquiterpenoids (1 and 2), as well as five known compounds (3-7), were isolated from the basidiomycete Trichaptum biforme. The structures of new compounds were elucidated by extensive spectroscopic methods, and the known compounds were identified by comparing their spectroscopic data with those reported in the literature. The cytotoxicities results against five human cancer cell lines of compounds 1 and 2 were negligible.
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Introduction
The Trichaptum biforme is an edible fungus belonging to the family Polyporaceae, which is mainly distributed in temperate regions and boreal forests zones throughout the world. 1 This fungus displays diverse pharmacological properties, including antimicrobial, antifungal, 2 decolorization of methylene blue, 3 degradation of pitch, 4 and delignification activities 5 . However, to date, the secondary metabolites of T. biforme have not been investigated further. 2 As a part of our search for diverse secondary metabolites from higher fungi, [6] [7] [8] [9] [10] [11] we conducted chemical investigations on cultures of T. biforme, which led to the isolation of two new drimane sesquiterpenoids, 11,12-epoxy-3α,6β,9α,11α-tetrahydroxydrimene (1) and 11,12-epoxy-3α,9α,11α-trihydroxydrimene (2), together with four known analogues, danilol (3), 12 isodrimeninol (4), 13, 14 3β,11,12-trihydroxydrimene (5), 15, 16 and 11,12-dihydroxydrimene (6), 16, 17 as well as one chain-shaped sesquiterpenoid, 2,10-dodecadiene-1,6,7-triol (7). 18 Herein, we report the isolation and structural elucidation of 1 and 2. All of these compounds were tested for their cytotoxicities against five human cancer cell lines.
Results and Discussion
Compound 1 was obtained as white powder. Its molecular formula C 15 Figure 1 . The HMBC spectrum (Figure 1 ) of 1 showed correlations from both δ H 1.36 (3H, s, Me-13) and 1.15 (3H, s, Me-14) to δ C 78.7 (d, C-3), 39.3 (s, C-4), and 41.4 (d, C-5), and from δ H 3.33 (1H, br. s, H-3) to C-5, indicated that C-3 and C-5 were attached to the quaternary carbon C-4. Furthermore, the HMBC correlations ( Figure 1 ) from δ H 2.43 (1H, m, H-1a) to δ C 78.5 (s, C-9), 38.8 (s, C-10), and 19.4 (q, C-15), and from δ H 2.30 (1H, d, H-5) to C-9, C-10, C-1, and C-15, revealed that C-1 and C-9 were attached to the quaternary carbon C-10 and the connectivity from C-5 to C-10. In addition, the HMBC correlations ( Figure  1 ) from δ H 4.19 (1H, dt, H-12b) to C-7, C-11, and C-9 revealed the connectivity of C-12 to C-8 and C-11 to C-12 via an oxygen atom, which formed a five-membered ring. The data described above gave a gross structure of 1 belonging to a drimane sesquiterpenoid, which was related to that of danilol (3), 8 except for two more hydroxy groups at C-6 and C-9 in 1. The relative configuration of 1 was deduced from the ROESY spectrum ( Figure 1 ). Biogenetically, the methyl group of Me-15 was β-oriented, whilst H-5 was α-oriented. 8 Therefore, the key ROESY correlation between Me-15 and H-11 allowed H-11 to be β-oriented, while the ROESY correlation of H-5/H-6 indicated that H-6 was β-oriented, Moreover, a 3D structure model of the ROESY correlation of Me-15/H-11 was determined and it was revealed that the OH-9 could only be α-oriented (Figure 1 ). The broad peak of H-3 indicated that the OH-3 was α-oriented. Therefore, compound 1 was elucidated as 11,12-epoxy-3α,6β,9,11α-tetrahydroxydrimene.
Compound 2 was deduced as the molecular formula C 15 (1H, m, H-7) and HMBC correlations from H-6 to δ C 122.9 (d, C-7) and 139.0 (s, C-8). The broad peak of H-3 (δ H 3.38, 1H, br. s) indicated that OH-3 was α-oriented. The ROESY correlations of Me-15/H-11 indicated that the relative configuration at C-9 and C-11 in 2 was the same as that of 1. Thus, compound 2 was elucidated as 11,12-epoxy-3α,9,11α-trihydroxydrimene.
Compounds 1 and 2 were evaluated for their cytotoxicities against five human cancer cell lines namely: SK-BR-3 breast, SMMC-7721 hepatocellular carcinoma, HL-60 myeloid leukemia, PANC-1 pancreatic cancer, and A-549 lung cancer cell lines, using the MTT method as reported previously. 19 Unfortunately, nither compound 1 or 2 displayed any cytotocicity activity againist these cancer cell lines (IC 50 > 40 μM).
Experimental Section
General Experimental Procedures. Optical rotations were measured on a Horiba SEPA-300 polarimeter. IR spectra were obtained on a Bruker Tensor 27 spectrometer with KBr pellets. 1D and 2D NMR experiments were performed on a Bruker AM-400, DRX-500 or AVANCE III-600 spectrometer with TMS as the internal standard. Chemical shifts (δ) were expressed in ppm with reference to the solvent signals. Mass spectra (MS) were recorded on a VG Auto Spec-3000 or an Fungal Material and Cultivation Condition. T. biforme was isolated from a tissue culture of its fruiting bodies, which was originally collected from Changbai Mountain in Jilin Province, China in 2009. The specimen was authenticated by Prof. Tuli Guer from Jilin Agricultural University. A voucher specimen was deposited in the Herbarium of Kunming Institute of Botany, Chinese Academy of Sciences. The culture medium consisted of glucose 5%, peptone 0.15%, yeast powder 0.5%, KH 2 PO 4 0.05% and MgSO 4 0.05%. Fermentation was conducted using a shaker at 24 °C and 150 rpm for 26 days.
Extraction and Isolation. The culture broth of T. biforme (20 L) was filtered, and the filtrate was extracted three times with EtOAc. The organic layer was concentrated under reduced pressure to give an oily residue (3.9 g) that was subjected to column chromatography (CC) over silica gel (200-300 mesh) eluting with CHCl 3 /MeOH (from 100:0 to 0:100) to derive fractions A-G. Fraction A (130 mg) was isolated by repeated CC on silica gel (petroleum ether-Me 2 CO) to give compounds 4 (2.3 mg), 5 (1.2 mg) and 6 (1.9 mg). Fraction C (88 mg) was subjected to Sephadex LH-20 CC (Me 2 CO) and purified by repeated CC on silica gel (petroleum ether-Me 2 CO) to derive compounds 3 (2.5 mg) and 7 (3.7 mg). Fraction E (600 mg) was subjected to Sephadex LH-20 CC (CHCl 3 -MeOH, 1:1) and purified by column chromatography on silica gel eluted with petroleum ether-acetone (3:1) to derive compound 2 (45.8 mg). Fraction G (200 mg) was isolated first by CC on silica gel eluted with petroleum etherEtOAc (1:4) and purified by Sephadex LH-20 (CHCl 3 -MeOH, 1:1) to afford compound 1 (21.3 mg). Epoxy-3α,6β,9α,11α- Cytotoxicity Assay. Five human cancer cell lines: SK-BR-3 breast, SMMC-7721 hepatocellular carcinoma, HL-60 myeloid leukemia, PANC-1 pancreatic cancer and A-549 lung cancer. All the cells were cultured in RPMI-1640 or DMEM medium (Hyclone, USA), supplemented with 10% fetal bovine serum (Hyclone, USA) in 5% CO 2 at 37 C. The cytotoxicity assay was performed according to the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well microplates. Briefly, 100 µL adherent cells were seeded into each well of 96-well cell culture plates and allowed to adhere for 12 h before isolated compound addition. The suspended cells were seeded just before the isolated compounds were added with an initial density of 1 × 10 5 cells/mL. Each tumor cell line was exposed to the test compound at concentrations of 0.0625, 0.32, 1.6, 8, and 40 μM in triplicates for 48 h, with cisplatin (sigma, USA) as a positive control. After the compound treatment, cell viability were detected and cell growth curve was graphed.
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